adverse reactions to l-asparaginase in children undergoing induction therapy for acute lymphocytic leukemia have previously been described and have been noted to include hypersensitivity reactions , pancreatitis , hepatic dysfunction , nephrotoxicity , and central nervous system dysfunction .
C0003993
asparaginase
C0030305
pancreatitis